A61K8/355

UROLITHIN COMBINATIONS

Described is a composition comprising: (a) a compound of formula (I), or a salt, prodrug, metabolite or derivative thereof;

##STR00001## wherein: A, B, C, D, W, X, Y and Z are each independently selected from H and OH; and (b) one of more agents selected from agents for improving skin health, wherein the agents for improving skin health are selected from one or more of the following: (i) one or more ceramides, for example, one or more phytoceramides; (ii) a carotenoid, for example, lycopene and/or lutein; c. zinc or a salt thereof; d. astaxanthin; and optionally e. L-lysine; f. one or more NAD boosters, for example, nicotinamide and/or co-enzyme Q.sub.10; g. eggshell membrane or an extract thereof; and/or h. biotin, or a derivative thereof.

ANTI-AGING EYE CREAM

A stable emulsion type anti-aging composition is in the form of an oil in water emulsion has a pleasing tactile feel and includes a blend of compounds including an elastase reducer, for example a C-glycoside derivative also known as hydroxypropyl tetrahydropyrantriol, and two or more compounds selected from the group consisting of cell proliferation agents, for example niacinamide, anti-inflammatory agents, for example Eperua falcata bark extract and collagen production agents, for example Gentiana lutea root extract, and combinations thereof.

Minoxidil adjuvant therapies
12527729 · 2026-01-20 · ·

Compositions and methods are disclosed herein for inducing (up-regulating) the expression of sulfotransferases in the hair follicles, e.g., the scalp. Increasing sulfotransferase is beneficial for metabolizing pro-drugs that require sulfonation to be activated, e.g., minoxidil sulfate is the active metabolite of minoxidil. A method for combining the compositions described herein with topical minoxidil to enhance minoxidil treatment for androgenetic alopecia is described. Additional methods and compositions include the use of retinoid X receptor agonists, retinoic acid receptor agonists, and nuclear receptor agonists in an RXR-NR heterodimer. Additional methods and compositions include the use of a topical solution containing an alkalinizing agent or an alkalinizing agent used with a penetration enhancer for up-regulating the sulfonating capacity of hair bearing skin, hair follicles, and/or keratinocyte cells. In addition, compositions and methods for increasing or decreasing the growth rate of hair follicles is disclosed by altering the intracellular pH.

Dyeing composition comprising an anthraquinone cationic direct dye, a polyol, an anionic surfactant and a nonionic polysaccharide
12544322 · 2026-02-10 · ·

The invention relates to a composition for dyeing human keratin fibers, preferably the hair, comprising:one or more anthraquinone cationic direct dyes,one or more polyols,one or more anionic surfactants, andone or more nonionic polysaccharides.

SKIN CARE PRODUCT WITH LAPACHOL
20260069517 · 2026-03-12 ·

A water-based composition containing lapachol is provided that includes water, a plurality of water-based and/or water-soluble components, a plurality of oil based and/or soluble components, lapachol. The lapachol is dissolved within one or more of the plurality of oil based and/or soluble components.